Study details
Enrolling now
Chloroquine for Atrial Fibrillation
University of South Florida
NCT IDNCT02932007ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
40
Study length
about 3.5 years
Ages
18+
Locations
1 site in FL
What this study is about
This trial is testing whether chloroquine can help stop persistent atrial fibrillation. It's a small pilot trial looking at the potential of chloroquine as a medication to manage this condition.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Chloroquine Phosphate
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
Antimalarial Agent [TC] (Nucleic Acid Synthesis Inhibitors)
Drug routes
oral (Oral Tablet)
Endpoints
Secondary: PR interval
Body systems
Cardiology / Heart